Our previous results have indicated that the increased expression of KDELR1 is strongly related to negative survival factors such as older age, a higher WHO grade, recurrence, IDH wild type, and 1p/19q non-codeletion status; therefore, we further investigated whether the expression of KDELR1 is related to the survival time of patients with gliomas. The gene discussed is IDH1; the disease is glioma.